Free Trial
ASX:MVF

Monash IVF Group (MVF) Stock Price, News & Analysis

Monash IVF Group logo

About Monash IVF Group Stock (ASX:MVF)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
9.00 million shs
Average Volume
N/A
Market Capitalization
A$455.87 million
P/E Ratio
N/A
Dividend Yield
4.27%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Monash IVF Group and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MVF Stock News Headlines

REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).tc pixel
See More Headlines

MVF Stock Analysis - Frequently Asked Questions

Monash IVF Group Limited (ASX:MVF) issued its quarterly earnings data on Monday, August, 27th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by $0.01. Monash IVF Group had a negative net margin of 2.56% and a negative trailing twelve-month return on equity of 2.52%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Monash IVF Group investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Surgery Partners (SGRY), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX).

Company Calendar

Last Earnings
8/27/2018
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
Financial Services
Current Symbol
ASX:MVF
CIK
N/A
Fax
N/A
Employees
997
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
8.25
Net Income
-A$6.53 million
Net Margins
-2.56%
Pretax Margin
N/A
Return on Equity
-2.52%
Return on Assets
-0.62%

Debt

Debt-to-Equity Ratio
55.96
Current Ratio
0.47
Quick Ratio
0.43

Sales & Book Value

Annual Sales
A$255.22 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
27.14
Book Value
A$0.64 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
389,640,000
Free Float
N/A
Market Cap
A$455.87 million
Optionable
Not Optionable
Beta
1.40
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (ASX:MVF) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners